Intravascular ultrasound–guided selection for early noninvasive cardiac allograft vasculopathy screening in heart transplant recipients
Clinical Transplantation2020Vol. 34(12), pp. e14124–e14124
Citations Over TimeTop 20% of 2020 papers
Lærke Marie Nelson, Kasper Rossing, Nikolaj Ihlemann, Søren Boesgaard, Thomas Engstrøm, Finn Gustafsson
Abstract
IVUS-guided selection for early noninvasive CAV screening appears to be safe and holds promise as a novel strategy for early risk stratification and CAV surveillance post-HTx.
Related Papers
- → Angiogenesis on Coronary Angiography Is a Marker for Accelerated Cardiac Allograft Vasculopathy as Assessed by Intravascular Ultrasound(2017)2 cited
- → Impact of everolimus on allograft vasculopathy the SDZ Rad/heart intravascular ultrasound study(2002)11 cited
- → Multi-center intravascular ultrasound validation study among heart transplant recipients: outcomes after 5 years(2004)3 cited
- → Intravascular Ultrasound Imaging. In vitro and vivo validation.(1992)5 cited
- → 667: The Use of Intravascular Ultrasound in the Diagnosis of Cardiac Allograft Vasculopathy in Pediatric Heart Transplant Recipients: A Ten Year Experience(2009)